Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Vaccinia virus/VACV H3L Protein, N-His

Catalog #:   YVV17901 Specific References (42) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: A0A0M4RY97
Protein length: Met1-Ile324
Overview

Catalog No.

YVV17901

Expression system

E. coli

Species

Vaccinia virus

Protein length

Met1-Ile324

Predicted molecular weight

39.59 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

A0A0M4RY97

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

MV heparin binding surface protein, VACV_IOC_B388_127

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Vaccinia virus/VACV H3L Protein
References

Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development., PMID:39994775

Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus., PMID:39321566

Exploring computational approaches to design mRNA Vaccine against vaccinia and Mpox viruses., PMID:39150224

Expression of F1L, a vaccinia virus H3L transmembrane protein analogue of orf virus, and its successful purification as a diagnostic antigen., PMID:39136814

Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity., PMID:37300753

Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens., PMID:36687315

New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization., PMID:35746695

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses., PMID:33675226

Molecular phylogeny of Capripoxviruses based on major immunodominant protein (P32) reveals circulation of host specific sheeppox and goatpox viruses in small ruminants of India., PMID:32711078

Molecular Modelling and Insilico Engineering of PapMV-CP Towards Display and Development of Capripox Viral Like Particles Based on Immunogenic P32 Envelop Protein is the Homologous of the Vaccinia-Viral H3L Gene: An Insilico Approach., PMID:32421016

Probing and pressing surfaces of hepatitis C virus-like particles., PMID:30897421

Phage display antibodies against ectromelia virus that neutralize variola virus: Selection and implementation for p35 neutralizing epitope mapping., PMID:29427674

Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models., PMID:28259752

Immunogenicity and protective efficacy of recombinant major envelope protein (rH3L) of buffalopox virus in animal models., PMID:26723250

Phylogenetic and histological variation in avipoxviruses isolated in South Africa., PMID:23860490

Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies., PMID:23133652

Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs., PMID:22100890

Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model., PMID:20587859

Attenuation of vaccinia virus by the expression of human Flt3 ligand., PMID:20504356

Phylogenetic analysis of three genes of Penguinpox virus corresponding to Vaccinia virus G8R (VLTF-1), A3L (P4b) and H3L reveals that it is most closely related to Turkeypox virus, Ostrichpox virus and Pigeonpox virus., PMID:19426497

Investigation of orf virus structure and morphogenesis using recombinants expressing FLAG-tagged envelope structural proteins: evidence for wrapped virus particles and egress from infected cells., PMID:19218206

Vaccinia virus proteins activate human dendritic cells to induce T cell responses in vitro., PMID:18977270

An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling., PMID:18480455

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine., PMID:18234801

Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox., PMID:17488297

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer., PMID:17200670

Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin., PMID:17166913

Avipoxvirus phylogenetics: identification of a PCR length polymorphism that discriminates between the two major clades., PMID:16847115

Comparative sequence analysis of envelope protein genes of Indian buffalopox virus isolates., PMID:16625321

Characterization of the major capsid proteins of myxoma virus particles using MALDI-TOF mass spectrometry., PMID:16226321

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice., PMID:16140750

Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts., PMID:15650188

Heparin binding activity of orf virus F1L protein., PMID:15351483

Identification and characterization of three immunodominant structural proteins of fowlpox virus., PMID:12208962

Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication., PMID:10906205

Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail., PMID:10906204

Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure., PMID:10729126

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo., PMID:10708453

A capripoxvirus detection PCR and antibody ELISA based on the major antigen P32, the homolog of the vaccinia virus H3L gene., PMID:10485266

The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39 kDa immunodominant protein., PMID:9930187

N-terminal amino acid sequences of vaccinia virus structural proteins., PMID:8030247

Conservation of gene structure and arrangement between vaccinia virus and orf virus., PMID:8317094

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Vaccinia virus/VACV H3L Protein, N-His [YVV17901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only